
AstraZeneca and ChemStress®
In this webinar, Dr. Raj Mistry, Senior Scientist, Cell Line Development & Engineering Department with AstraZeneca, discusses how a novel hydrogen peroxide evolved CHO host can improve the expression of industrially relevant difficult-to-express bispecific antibodies. Dr. Mistry will highlight the role of ValitaCell’s ChemStress® technology in this study.
Watch Now